James Kim completed his B.A. in chemistry and classical Greek at Amherst College in 1990. He then joined the M.D.-Ph.D. program at the University of Rochester School of Medicine and Dentistry. He did his graduate research in the laboratory of Dr. Douglas Turner and received a Ph.D. in biophysical chemistry in 1997, with a focus on RNA thermodynamics and prediction of RNA secondary structure from sequence. He completed his M.D. in 1999.
He served a residency in internal medicine at University of Rochester Strong Memorial Hospital, and a fellowship in medical oncology at Johns Hopkins School of Medicine.
Dr. Kim completed postdoctoral research in the lab of Dr. Philip Beachy at Stanford University. There he identified and characterized itraconazole, a well-known antifungal drug, as a novel Hedgehog pathway inhibitor with a distinct mechanism of action from other Hh pathway antagonists.
For more information, please see Dr. Kim's faculty profile.